Pradaxa Reversal Rx Approved
The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects.
How to Choose an Anticoagulant
If you need to take an anticoagulant — popularly known as a blood thinner — you don’t want it to cause bleeding, but some might raise your bleeding risk.
Abnormal Heartbeat Rx May Pose Major Bleeding Risk
When the US Food and Drug Administration (FDA) approved dabigatran in 2010, it highlighted the medication's ability to prevent stroke. Since then, some have raised concerns that the blood-thinning medication may cause severe bleeding.
GI Bleeding Higher in Pradaxa vs. Warfarin
The prescription blood-thinners Pradaxa (dabigatran) and warfarin aim to reduce stroke and other cardiovascular disorders, but like most medications, they do carry some risks.
FDA Compares Risks of Pradaxa and Warfarin
FDA research has taken a closer look at the risks of two medications commonly used to lower the risk for stroke and blood clots.
Blood Thinners Recommended for AFib Patients
People with atrial fibrillation, a common heart rhythm disorder, face a high likelihood of stroke. To reduce the risk, the American Academy of Neurology recommends taking anticoagulants.
Rx for Arrhythmia Shortens Hospital Stay
The average price for a day in the hospital can be close to $4,000. So anything that can safely reduce hospital days would be welcome by both patients and insurers.
Does Stroke Rx Cause Excess Bleeding?
People with abnormal heart rhythms are at a higher risk of getting blood clots, which can cause a stroke. A blood-thinning medication may help. But some questions remain if these medications cause the bleeding.
Pradaxa Linked to Heart Attack Risk
Blood thinner dabigatran ( Pradaxa ), approved in 2010 to prevent stroke in patients with atrial fibrillation, a common heart arrhythmia, is linked to an increased risk of heart attack, a new trial suggests.
Blood Thinner Pradaxa May Lead to Bleeding
U.S. Food and Drug Administration officials are taking a second look at blood thinning drug Pradaxa ( dabigatran etexilate mesylate ) after reports of serious, potentially fatal, bleeding.